Ventyx Biosciences, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACLX
Arcellx, Inc. |
$77.58 | $2.72 B | -49.3 | 130 | $110.32 M |
ASND
Ascendis Pharma A/S |
$138.79 | $7.77 B | -14.19 | 879 | $266.72 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
GPCR
Structure Therapeutics Inc. |
$28.25 | $2.47 B | -23.59 | 136 | $0 |
IDYA
IDEAYA Biosciences, Inc. |
$25.30 | $2.88 B | -19 | 124 | $23.39 M |
IMCR
Immunocore Holdings plc |
$28.66 | $2.08 B | -26.72 | 497 | $249.43 M |
NUVL
Nuvalent, Inc. |
$82.65 | $5.11 B | -32.72 | 127 | $0 |
PCVX
Vaxcyte, Inc. |
$85.91 | $7.72 B | -16.54 | 254 | $0 |
PTGX
Protagonist Therapeutics, Inc. |
$39.30 | $2.04 B | 13.7 | 126 | $60.00 M |
REPL
Replimune Group, Inc. |
$12.50 | $485.18 M | -2.44 | 331 | $0 |
SNDX
Syndax Pharmaceuticals, Inc. |
$13.07 | $1.66 B | -6.02 | 184 | $0 |
TVTX
Travere Therapeutics, Inc. |
$17.13 | $542.80 M | -1.32 | 380 | $145.24 M |
UTHR
United Therapeutics Corporation |
$360.87 | $12.20 B | 13.02 | 1168 | $2.33 B |
VRNA
Verona Pharma plc |
$45.04 | $983.52 M | -15.16 | 79 | $0 |